Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
07/2003
07/10/2003WO2003055302A1 Knockout swine and methods for making the same
07/10/2003WO2003055301A2 Insect holder
07/10/2003WO2003000861A3 Eukaryotic genes involved in adult lifespan regulation
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002059326A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2001088096A3 Ovine tissue for xenotransplantation
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030131366 Non-human mammals comprising cells expressing vector-borne mouse PTTG carboxy-terminal-related DNA
07/10/2003US20030131364 Screening for Alzheimer's disease
07/10/2003US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins
07/10/2003US20030130219 Classification of genes; medical diagnosis
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129686 Novel nucleic acid and polypeptide molecules
07/10/2003US20030129663 Methods and compositions for modulating oxidized ldl transport
07/10/2003US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity
07/10/2003US20030129610 New QTL's on chromosomes X, 2, 6 and 7 of pigs
07/10/2003US20030129171 Cloning mastitis gene; muscular disorders
07/10/2003US20030129091 Medical diagnosis; reducing stresses on sperm; artificial insemination
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471035A1 Knockout swine and methods for making the same
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470666A1 Secreted protein
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325678A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same
07/09/2003EP1325144A2 Chromosomal vectors and uses thereof
07/09/2003EP1325137A2 Truncated phosphodiesterase-7 polypeptides
07/09/2003EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors
07/09/2003EP1325124A2 Clk-2, cex-7 and coq-4 genes, and uses thereof
07/09/2003EP1324652A2 Transgenic drosophila melanogaster expressing beta amyloid
07/09/2003EP0626012B1 Homogenotization of gene-targeting events
07/08/2003US6590139 Method for producing cloned cows
07/08/2003CA2287794C Crop pollination method by insects
07/08/2003CA2263883C Kuz, a novel family of metalloproteases
07/03/2003WO2003054203A1 Isolation tool for viable c-kit expressing cells
07/03/2003WO2003054188A2 Seminal vesicle tissue-specific promoters and uses thereof
07/03/2003WO2003054182A2 Production of butyrylcholinesterases in transgenic mammals
07/03/2003WO2003054170A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
07/03/2003WO2003054169A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
07/03/2003WO2003054167A2 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
07/03/2003WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same
07/03/2003WO2003054151A2 Generation of transgenic mice by transgene-mediated rescue of spermatogenesis
07/03/2003WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053143A2 Method and apparatus for butane-enhanced aquatic plant and animal growth
07/03/2003WO2003053139A1 Disruption of the phosphodiesterase 10 gene
07/03/2003WO2003053138A1 Transgenic expression of glycogen synthase kinase 3 in muscle
07/03/2003WO2003053136A2 Triple transgenic mouse model of alzheimer's disease
07/03/2003WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
07/03/2003WO2003022220A3 Method of generating a transgenic livestock animal
07/03/2003WO2002012447B1 Isolation and use of solid tumor stem cells
07/03/2003US20030126629 Production of a transgenic avian by cytoplasmic injection
07/03/2003US20030126628 Avian oviduct regulatory sequences for controlling expression of interferon in transgenic cells; bioreactors
07/03/2003US20030126627 Beta amyloid precursor protein linked to muscle specific promoter (creatine kinase) for diagnosis and treatment of age related muscle disorders; screening for compounds which reduce beta amyloid protein proteolytic fragments
07/03/2003US20030126626 Rodent model which cultures human liver cells for regeneration of tissues, providing alternative to liver transplantation; side effect reduction; drug screening
07/03/2003US20030126625 Transgenic roundworm for monitoring inhibitors of protein secretion pathways; parasiticides; disease resistant plants
07/03/2003US20030126624 Chimeric DNA-binding proteins
07/03/2003US20030124668 Plasmid for use in gene expression, mapping and mutagenesis; transposases
07/03/2003US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2)
07/03/2003US20030124507 Method of generating conditionally expressed mutant cells using expressible antisense sequences
07/03/2003US20030124123 Also an IL-12 anti-idiotype antibody to the antibody
07/03/2003US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma
07/03/2003US20030124111 Antimicrobial agent
07/03/2003US20030124107 PAK5-related compositions and methods
07/03/2003US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof
07/03/2003CA2471198A1 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
07/03/2003CA2471160A1 Seminal vesicle tissue-specific promoters and uses thereof
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2468778A1 Isolation tool for viable c-kit expressing cells
07/03/2003CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor
07/02/2003EP1323821A1 Process for producing normal parenchymal cells, tissue or organ by bioincubator
07/02/2003EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
07/02/2003EP1322763A2 Listeria inocua , genome and applications
07/02/2003EP1322757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/02/2003EP1322151A2 Method of producing non-human mammals
07/02/2003EP0873491B1 Ceramic packing with channels for thermal and catalytic beds
07/02/2003EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
07/02/2003CN2558216Y Cocoon rating table
07/02/2003CN1427887A Pluripotent cells comprising allogenic nucleus and mitochondria
07/02/2003CN1426679A Production method of hybridized variety of black eye large rabbit
07/01/2003US6586656 Transgenic rodents harboring APP allele having Swedish mutation
07/01/2003US6586655 Expression of human estrogen receptors in transgenic mice
07/01/2003US6586395 Apoptosis-modulating proteins
07/01/2003US6586251 Genetically engineering cells; obtain cells, transform with preferential vector, recover transformed cells, propagate, monitor cells for preferential activity
07/01/2003US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
07/01/2003US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a
06/2003
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003051109A1 Cell culture system and methods of use
06/26/2003WO2003026396A3 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003US20030121068 Vector encoding suicide and marker constructs